Lung Adenocarcinoma
What's New
Last Posted: Jun 25, 2024
- Deep Learning Analysis for Predicting Tumor Spread through Air Space in Early-Stage Lung Adenocarcinoma Pathology Images.
De-Xiang Ou et al. Cancers (Basel) 2024 16(11) - A deep learning-based radiomics model for predicting lymph node status from lung adenocarcinoma.
Hui Xie et al. BMC Med Imaging 2024 24(1) 121 - Construction of a predictive model for bone metastasis from first primary lung adenocarcinoma within 3 cm based on machine learning algorithm: a retrospective study.
Yu Zhang et al. PeerJ 2024 12e17098 - Predictive value of multiple imaging predictive models for spread through air spaces of lung adenocarcinoma: A systematic review and network meta‑analysis.
Cong Liu et al. Oncol Lett 2024 27(3) 122 - Effectiveness of next-generation sequencing for patients with advanced non-small-cell lung cancer: a population-based registry study.
D-W Kang et al. ESMO Open 2024 9(1) 102200 - Predicting occult lymph node metastasis in solid-predominantly invasive lung adenocarcinoma across multiple centers using radiomics-deep learning fusion model.
Weiwei Tian et al. Cancer Imaging 2024 24(1) 8 - A DNA Replication Stress-Based Prognostic Model for Lung Adenocarcinoma.
S Shi et al. Acta Naturae 2023 15(3) 100-110 - A Machine Learning-Based Model to Predict In-Hospital Mortality of Lung Cancer Patients: A Population-Based Study of 523,959 Cases.
Que N N Tran et al. Adv Respir Med 2023 91(4) 310-323 - Deep learning-enhanced radiomics for histologic classification and grade stratification of stage IA lung adenocarcinoma: a multicenter study.
Guotian Pei et al. Front Oncol 2023 131224455 - Standardized classification of lung adenocarcinoma subtypes and improvement of grading assessment through deep learning.
Kris Lami et al. Am J Pathol 2023
More
About Rare Diseases PHGKB
Rare Disease PHGKB is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other information that address the public health impact and translation of genomic and other precision health discoveries into improved health outcomes related to rare diseases...more
Content Summary
Selected Rare Diseases
- Alpha-1 Antitrypsin Deficiency
- Amyotrophic Lateral Sclerosis
- Brugada Syndrome
- Cerebral Palsy
- Cystic Fibrosis
- Duchenne Muscular Dystrophy
- Eclampsia
- Erythema Multiforme
- Familial Mediterranean Fever
- Fragile X Syndrome
- Gaucher Disease
- Glomerulonephritis
- Graves Disease
- Hemophilia
- Huntington Disease
- Microcephaly
- Myasthenia Gravis
- Phenylketonuria
- Retinitis Pigmentosa
- Severe Combined Immunodeficiency
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Content source: